Author:
Wang Yingwen,Fu Weijia,Zhang Yuejie,Wang Daoyang,Gu Ying,Wang Weibing,Xu Hong,Ge Xiaoling,Ye Chengjie,Fang Jinwu,Su Ling,Wang Jiayu,He Wen,Zhang Xiaobo,Feng Rui
Abstract
AbstractArtificial intelligence (AI) decision support systems in pediatric healthcare have a complex application background. As an AI decision support system (AI-DSS) can be costly, once applied, it is crucial to focus on its performance, interpret its success, and then monitor and update it to ensure ongoing success consistently. Therefore, a set of evaluation indicators was explicitly developed for AI-DSS in pediatric healthcare, enabling continuous and systematic performance monitoring. The study unfolded in two stages. The first stage encompassed establishing the evaluation indicator set through a literature review, a focus group interview, and expert consultation using the Delphi method. In the second stage, weight analysis was conducted. Subjective weights were calculated based on expert opinions through analytic hierarchy process, while objective weights were determined using the entropy weight method. Subsequently, subject and object weights were synthesized to form the combined weight. In the two rounds of expert consultation, the authority coefficients were 0.834 and 0.846, Kendall's coordination coefficient was 0.135 in Round 1 and 0.312 in Round 2. The final evaluation indicator set has three first-class indicators, fifteen second-class indicators, and forty-seven third-class indicators. Indicator I-1(Organizational performance) carries the highest weight, followed by Indicator I-2(Societal performance) and Indicator I-3(User experience performance) in the objective and combined weights. Conversely, 'Societal performance' holds the most weight among the subjective weights, followed by 'Organizational performance' and 'User experience performance'. In this study, a comprehensive and specialized set of evaluation indicators for the AI-DSS in the pediatric outpatient clinic was established, and then implemented. Continuous evaluation still requires long-term data collection to optimize the weight proportions of the established indicators.
Funder
Science and Technology Commission of Shanghai Municipality
National Key R&D Program of China
2021 Artificial Intelligence Technology Support Special Directional Project
Shanghai Municipal Hospital Pediatric Specialist Alliance
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Administration., U. F. a. D. FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems: FDA news release. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm604357.htm. Published April 11, 2018. Accessed 17 April 2024.
2. He, J. et al. The practical implementation of artificial intelligence technologies in medicine. Nat. Med. 25, 30–36. https://doi.org/10.1038/s41591-018-0307-0 (2019).
3. Sugano, K., Moss, S. F. & Kuipers, E. J. Gastric intestinal metaplasia: Real culprit or innocent bystander as a precancerous condition for gastric cancer?. Gastroenterology 165, 1352-1366.e1351. https://doi.org/10.1053/j.gastro.2023.08.028 (2023).
4. Vishwanathaiah, S., Fageeh, H. N., Khanagar, S. B. & Maganur, P. C. Artificial intelligence its uses and application in pediatric dentistry: A review. Biomedicines 11, 788. https://doi.org/10.3390/biomedicines11030788 (2023).
5. Liang, H. et al. Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence. Nat. Med. 25, 433–438. https://doi.org/10.1038/s41591-018-0335-9 (2019).